,i #aafth ,,congress #ast ,session ,h4 ,r4 #bhef ,,in ,,the ,,house ,,of ,,representatives ,may #ba1 #bjai,mr4 ,hudson 7for himself1 ,mr4 ,biggs1 ,mr4 ,gaetz1 ,mr4 ,gosar1 ,mr4 ,david ,p4 ,roe of ,tennessee1 ,mr4 ,meuser1 ,mr4 ,mullin1 ,mr4 ,grothman1 ,mr4 ,luetkemeyer1 ,mr4 ,johnson of ,louisiana1 ,mr4 ,budd1 ,mr4 ,carter of ,georgia1 ,mr4 ,meadows1 ,mr4 ,duncan1 ,mr4 ,banks1 ,mr4 ,hunter1 ,mr4 ,brooks of ,alabama1 ,mr4 ,buck1 ,mr4 ,gibbs1 ,mr4 ,norman1 ,mr4 ,wright1 ,mr4 ,gooden1 ,mr4 ,abraham1 ,mr4 ,weber of ,texas1 ,mr4 ,harris1 ,mr4 ,la,malfa1 ,mr4 ,joyce of ,pennsylvania1 ,mr4 ,mc,clintock1 and ,mr4 ,kelly of ,mississippi7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend title ,,xix of the ,social ,security ,act to prohibit ,federal ,medicaid funding for the administrative costs of providing health benefits to individuals who are unauthorized immigrants4 #a4 ,short title ,this ,act may be cited as the ,protect ,medicaid ,act4 #b4 ,prohibiting ,federal ,medicaid funding for the administrative costs of providing health benefits to individuals who are unauthorized immigrants ,section #aijc7;i7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;b7i77 is amended-- 7#a7 in paragraph 7#bf71 by striking 2 or and inserting a semicolon2 7#b7 in paragraph 7#bg71 by striking the period at the end and inserting 2 or2 and 7#c7 by inserting after paragraph 7#bg7 the following new paragraph3 7#bh7 with respect to any amounts expended for the administration of a ,state program that provides health benefits to noncitizens who are ineligible for medical assistance under this title on the basis of not having a satisfactory immigration status 7as defined in section #aacg7;d77#a77;,b77iii77 7except that such prohibition shall not be construed as prohibiting payment under the preceding provisions of this section for costs attributable to the establishment or operation of a system designed to ensure compliance with such prohibition74 4 #c4 ,inspector ,general report ,not later than #ahj days after the date of enactment of this ,act1 the ,inspector ,general of the ,department of ,health and ,human ,services shall submit to ,congress a report that includes the following information with respect to ,states that provide health benefits to noncitizens who are ineligible on the basis of immigration status for medical assistance under title ,,xix of the ,social ,security ,act 7#db ,u4,s4,c4 #acif et seq473 7#a7 ,how such ,states separate amounts expended on the administrative costs related to the ,state's ,medicaid program and amounts expended on administrative costs related to providing health benefits to such noncitizens4 7#b7 ,the types of procedures1 protocols1 or systems that such ,states employ to ensure that they are in full compliance with prohibitions on the use of ,federal funding to provide health benefits to such noncitizens and how effective they are at ensuring compliance4 7#c7 ,a description of ,states' methods of financing ,state programs that provide health benefits to noncitizens who are ineligible for medical assistance due to not having a satisfactory immigration status1 including through the increased use of provider taxes and intergovernmental transfers to finance the non-,federal share of expenditures under the ,state ,medicaid program for medical assistance provided to individuals who are not so ineligible4 7#d7 ,an analysis of-- 7,a7 the extent to which such noncitizens are provided covered outpatient drugs purchased under-- 7i7 the ,medicaid ,drug ,rebate ,program under section #aibg of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h72 or 7ii7 the drug discount program under section #cdj;,b of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bef;b72 and 7,b7 the effect that the provision to such noncitizens of covered outpatient drugs purchased under the programs described in subparagraph 7,a7 has on the average manufacturer price 7as defined in section #aibg7k77#a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h7k77#a777 of such drugs1 including whether the average manufacturer price for such drugs would be lower if no drugs purchased under such programs were provided to such noncitizens4